Phreesia price target raised to $28 from $25 at Citi

Citi analyst Daniel Grosslight raised the firm’s price target on Phreesia to $28 from $25 and keeps a Neutral rating on the shares. The company reported another solid quarter that exceeded expectations, largely due to new provider adds, Grosslight tells investors in a research note. He raised the price target to reflect the strong quarter and less uncertainty around achievability of profitability in fiscal 2025.